Drug Discovery World

AUGUST 29, 2024

Now, with HT-SPR, researchers have the ability to screen entire antibody and small molecule libraries, along with characterising epitopes, so there is way more data available at the earliest stages of drug discovery than ever before.” The post Tech Focus: How is HTS accelerating early-stage drug discovery?

Small Molecule 147

Small Molecule Drugs Protein Expression Assay Development 147

Drug Discovery World

FEBRUARY 5, 2024

Opening keynote Following a change to the schedule, Juliet Williams of Kymera Therapeutics launched the event with a popular keynote talk ‘Solving Big Problems with Small Molecule Degraders’.

Small Molecule 162

Small Molecule Assay Development Production Science 162

Drug Discovery World

SEPTEMBER 29, 2022

In this listicle, SAMDITech outlines the benefits of outsourcing models in the pharmaceutical industry, looking past perceived costs to the value outsourcing can bring. . CROs offer an established infrastructure to develop, initiate, execute, and progress drug discovery programs towards the clinic.

Small Molecule 130

Small Molecule Assay Development DNA Biochemical Assays 130

PPD

OCTOBER 18, 2023

There has been an unprecedented expansion of different types of pharmaceutical therapies, as well as a change in the overall approach to health care. 1 With this growth comes increased demands for laboratory services at all steps across the development process.

Laboratories 52

Laboratories Assay Development Small Molecule Packaging 52

Sygnature Discovery

JUNE 17, 2024

From hit finding and target engagement studies, to the characterisation of kinetic properties for late-stage candidate molecules, we believe that a biophysical approach complements other assays to deliver a fuller picture of binding behaviour to produce more effective therapeutics.

Biophysical Assays 52

Biophysical Assays Screening Hits Fragment Screening Assay Development 52

Drug Target Review

NOVEMBER 1, 2023

The mission of the CCDD is to discover novel small-molecule therapeutics for the treatment of cancer and progress them to hypothesis testing phase 1 clinical trials. We support the drug discovery projects of the CCDD with assay development and screening, biophysics, structural biology and recombinant protein production.

Fragment Screening 96

Fragment Screening Biochemical Assays Small Molecule Biophysical Assays 96

Elrig

APRIL 29, 2024

Harini joined Serna Bio in early 2021 and has been an integral part of the multidisciplinary teamworking on target ID platform development to drug discovery. My role involved generating and characterizing complex proteins critical for biological assay development, hit discovery, and structural biology.

Bioinformatics 59

Bioinformatics Molecular Biology Drugs Cell Based Assays 59